| Prescribed Drug Use and Aneurysmal Subarachnoid Hemorrhage Incidence: A Drug-Wide Association Study JP Kanning, S Abtahi, C Schnier, OH Klungel, MI Geerlings, YM Ruigrok Neurology 102 (12), e209479, 2024 | | 2024 |
| Public's perspective on COVID-19 adenovirus vector vaccines after thrombosis with thrombocytopenia syndrome (TTS) reports and associated regulatory actions–A cross-sectional … C Buhl, R Jacobsen, AB Almarsdóttir, S Abtahi, A Andersen, E Deligianni, ... Vaccine 42 (3), 556-563, 2024 | 1 | 2024 |
| Cross-regional data initiative for the assessment and development of treatment for neurological and mental disorders DHT Tsai, JS Bell, S Abtahi, BN Baak, MT Bazelier, R Brauer, AYL Chan, ... Clinical epidemiology, 1241-1252, 2023 | 1 | 2023 |
| Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy … J Riera-Arnau, V Hoxhaj, M Gamba, M Sabaté, E Ballarín, CE Durán, ... Frontiers Media, 2023 | | 2023 |
| Impact of the 2018 revised Pregnancy Prevention Programme by the European Medicines Agency on the use of oral retinoids in females of childbearing age in Denmark, Italy … CE Durán, J Riera-Arnau, S Abtahi, R Pajouheshnia, V Hoxhaj, M Gamba, ... Frontiers in Pharmacology 14, 1207976, 2023 | 4 | 2023 |
| Impact of 2018 EU risk minimisation measures and revised pregnancy prevention programme on utilisation and prescribing trends of medicinal products containing valproate: an … S Abtahi, R Pajouheshnia, CE Durán, J Riera-Arnau, M Gamba, E Alsina, ... Drug Safety 46 (7), 689-702, 2023 | 5 | 2023 |
| Response to:‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis … S Abtahi, JHM Driessen, AM Burden, PC Souverein, JP Van Den Bergh, ... Annals of the rheumatic diseases 82 (6), e143-e143, 2023 | 1 | 2023 |
| Oral Presentation: Impact of the 2018 Pregnancy Prevention Program on the Use of Oral Retinoids in Childbearing Age Females in Europe C Duran, JR Arnau, S Abtahi, R Pajouheshnia, M Gamba, P García, ... Drug Safety 45 (10), 1118-1119, 2022 | | 2022 |
| Flash presentation: Impact of 2018 EU Risk Minimisation Measures and Revised Pregnancy Prevention Programme on Utilisation and Prescribing Trends of Valproates S Abtahi, R Pajouheshnia, C Duran-Salinas, J Riera-Arnau, M Gamba, ... Drug Safety 45 (10), 1312-1313, 2022 | | 2022 |
| Biological disease-modifying antirheumatic drugs and osteoporotic fracture risk in patients with rheumatoid arthritis: a Danish cohort study S Abtahi, R Cordtz, L Dreyer, JHM Driessen, A Boonen, AM Burden The American Journal of Medicine 135 (7), 879-888. e3, 2022 | 11 | 2022 |
| Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint … A van Veelen, S Abtahi, P Souverein, JHM Driessen, OH Klungel, ... Cancer Epidemiology 78, 102149, 2022 | 4 | 2022 |
| Low-dose oral glucocorticoid therapy and risk of osteoporotic fractures in patients with rheumatoid arthritis: a cohort study using the Clinical Practice Research Datalink S Abtahi, JHM Driessen, AM Burden, PC Souverein, JP van den Bergh, ... Rheumatology 61 (4), 1448-1458, 2022 | 23 | 2022 |
| Biologic Disease-modifying Antirheumatic Drugs and Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: a Danish Cohort Study with Prevalent New-user Design S Abtahi, R Cordtz, L Dreyer, JHM Driessen, F de Vries, A Boonen, ... Journal of Bone and Mineral Research 37 (Suppl. 1), 61, 2022 | | 2022 |
| Osteoporotic Fractures: Relation to Mortality, Medication Use, and Rheumatoid Arthritis S Abtahi Maastricht University, 2021 | | 2021 |
| Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis: a population-based cohort study S Abtahi, JHM Driessen, AM Burden, PC Souverein, JP van den Bergh, ... Annals of the rheumatic diseases 80 (4), 423-431, 2021 | 32 | 2021 |
| Response to:‘Correspondence on ‘Concomitant use of oral glucocorticoids and proton pump inhibitors and risk of osteoporotic fractures among patients with rheumatoid arthritis … S Abtahi, JHM Driessen, AM Burden, PC Souverein, JP van den Bergh, ... Annals of the Rheumatic Diseases, 2021 | | 2021 |
| Concomitant Use of Oral Glucocorticoids and Proton Punip Inhibitors and Risk of Osteoporotic Fractures among Patients with Rheumatoid Arthritis: A Population-based Cohort Study S Abtahi, JHM Driessen, AM Burden, P Souverein, JP van den Bergh, ... JOURNAL OF BONE AND MINERAL RESEARCH 35, 217-218, 2020 | | 2020 |
| The Effect of Low-dose Oral Glucocorticoid Therapy on Osteoporotic Fracture Risk in Patients with Rheumatoid Arthritis: the UK Clinical Practice Research Datalink S Abtahi, JHM Driessen, AM Burden, P Souverein, JP van den Bergh, ... JOURNAL OF BONE AND MINERAL RESEARCH 35, 44-44, 2020 | | 2020 |
| The effect of low-dose oral glucocorticoid therapy on osteoporotic fracture risk in patients with rheumatoid arthritis F de Vries, A Driessen, A Burden, P Souverein, T van Staa, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 29, 284-285, 2020 | | 2020 |
| The association of oral bisphosphonate use with mortality risk following a major osteoporotic fracture in the United Kingdom: population-based cohort study S Abtahi, AM Burden, P Geusens, JP van den Bergh, T van Staa, ... Journal of the American Medical Directors Association 21 (6), 811-816, 2020 | 12 | 2020 |
Frank de VriesProfessor Emeritus, The Netherlands在 fdevries.com 的电子邮件经过验证
